116 related articles for article (PubMed ID: 11856580)
21. Analysis of Marek's disease virus serotype 1-specific phosphorylated polypeptides in virus-infected cells and Marek's disease lymphoblastoid cells.
Nakajima K; Ikuta K; Naito M; Ueda S; Kato S; Hirai K
J Gen Virol; 1987 May; 68 ( Pt 5)():1379-89. PubMed ID: 3033141
[TBL] [Abstract][Full Text] [Related]
22. Preparation of monoclonal antibodies against Marek's disease virus serotype 1 glycoprotein D expressed by a recombinant baculovirus.
Ono M; Jang HK; Maeda K; Kawaguchi Y; Tohya Y; Niikura M; Mikami T
Virus Res; 1995 Oct; 38(2-3):219-30. PubMed ID: 8578860
[TBL] [Abstract][Full Text] [Related]
23. Functional anatomy of herpes simplex virus 1 overlapping genes encoding infected-cell protein 22 and US1.5 protein.
Ogle WO; Roizman B
J Virol; 1999 May; 73(5):4305-15. PubMed ID: 10196329
[TBL] [Abstract][Full Text] [Related]
24. Kinetic expression analysis of the cluster mdv1-mir-M9-M4, genes meq and vIL-8 differs between the lytic and latent phases of Marek's disease virus infection.
Coupeau D; Dambrine G; Rasschaert D
J Gen Virol; 2012 Jul; 93(Pt 7):1519-1529. PubMed ID: 22442112
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the regulatory function of the ICP22 protein of equine herpesvirus type 1.
Holden VR; Zhao Y; Thompson Y; Caughman GB; Smith RH; O'Callaghan DJ
Virology; 1995 Jul; 210(2):273-82. PubMed ID: 7618267
[TBL] [Abstract][Full Text] [Related]
26. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
[TBL] [Abstract][Full Text] [Related]
27. Effects of different promoters on the protective efficacy of recombinant Marek's disease virus type 1 expressing the VP2 gene of infectious bursal disease virus.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Gao Y; Cui H; Qi X; Zhong L; Wang X
Vaccine; 2016 Nov; 34(47):5744-5750. PubMed ID: 27742216
[TBL] [Abstract][Full Text] [Related]
28. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
Banders UT; Coussens PM
Virology; 1994 Feb; 199(1):1-10. PubMed ID: 8116231
[TBL] [Abstract][Full Text] [Related]
29. Transactivation of the Rous sarcoma virus long terminal repeat promoter by Marek's disease virus.
Tieber VL; Zalinskis LL; Silva RF; Finkelstein A; Coussens PM
Virology; 1990 Dec; 179(2):719-27. PubMed ID: 2173259
[TBL] [Abstract][Full Text] [Related]
30. Construction of recombinant Marek's disease virus (MDV) lacking the meq oncogene and co-expressing AIV-H9N2 HA and NA genes under control of exogenous promoters.
Zhang Z; Chen W; Ma C; Zhao P; Duan L; Zhang F; Sun A; Li Y; Su H; Li S; Cui H; Cui Z
J Biotechnol; 2014 Jul; 181():45-54. PubMed ID: 24709399
[TBL] [Abstract][Full Text] [Related]
31. Construction of recombinant Marek's disease virus type 1 (MDV1) expressing the Escherichia coli lacZ gene as a possible live vaccine vector: the US10 gene of MDV1 as a stable insertion site.
Sakaguchi M; Hirayama Y; Maeda H; Matsuo K; Yamamoto M; Hirai K
Vaccine; 1994 Aug; 12(10):953-7. PubMed ID: 7975837
[TBL] [Abstract][Full Text] [Related]
32. Characterization and expression of the Marek's disease virus serotype 2 glycoprotein E in recombinant baculovirus-infected cells: initial analysis of its DNA sequence and antigenic properties.
Jang HK; Niikura M; Song CS; Mikami T
Virus Res; 1997 May; 48(2):111-23. PubMed ID: 9175249
[TBL] [Abstract][Full Text] [Related]
33. Transactivation of latent Marek's disease herpesvirus genes in QT35, a quail fibroblast cell line, by herpesvirus of turkeys.
Yamaguchi T; Kaplan SL; Wakenell P; Schat KA
J Virol; 2000 Nov; 74(21):10176-86. PubMed ID: 11024146
[TBL] [Abstract][Full Text] [Related]
34. The genetic organization and transcriptional analysis of the short unique region in the genome of nononcogenic Marek's disease virus serotype 2.
Jang HK; Ono M; Kim TJ; Izumiya Y; Damiani AM; Matsumura T; Niikura M; Kai C; Mikami T
Virus Res; 1998 Nov; 58(1-2):137-47. PubMed ID: 9879770
[TBL] [Abstract][Full Text] [Related]
35. Replicating Marek's disease virus (MDV) serotype 2 DNA with inserted MDV serotype 1 DNA sequences in a Marek's disease lymphoblastoid cell line MSB1-41C.
Hirai K; Yamada M; Arao Y; Kato S; Nii S
Arch Virol; 1990; 114(3-4):153-65. PubMed ID: 2173523
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
[TBL] [Abstract][Full Text] [Related]
37. Marek's disease virus serotype 2 glycoprotein I gene: nucleotide sequence and expression by a recombinant baculovirus.
Jang HK; Ono M; Kim TJ; Cai JS; Tsushima Y; Niikura M; Mikami T
J Vet Med Sci; 1996 Nov; 58(11):1057-66. PubMed ID: 8959652
[TBL] [Abstract][Full Text] [Related]
38. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
[TBL] [Abstract][Full Text] [Related]
39. Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1.
Sakaguchi M; Nakamura H; Sonoda K; Okamura H; Yokogawa K; Matsuo K; Hira K
Vaccine; 1998 Mar; 16(5):472-9. PubMed ID: 9491501
[TBL] [Abstract][Full Text] [Related]
40. Hyperediting by ADAR1 of a new herpesvirus lncRNA during the lytic phase of the oncogenic Marek's disease virus.
Figueroa T; Boumart I; Coupeau D; Rasschaert D
J Gen Virol; 2016 Nov; 97(11):2973-2988. PubMed ID: 27655063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
